Clinical Trials for Myeloma

Find clinical trials for myeloma. Discover research opportunities and treatment options in your area.

25 Active Trials Found

Showing 25 trials on this page

Page 1 of 2

Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma

NCT ID: NCT06066359

This clinical trial is investigating a new treatment for patients with relapsed or refractory multiple myeloma, a type of blood cancer. The treatment involves using specially engineered natural kil...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma

NCT ID: NCT05055063

This clinical trial is studying a new treatment called Belantamab Mafodotin for patients with high-risk smoldering multiple myeloma, a type of blood cancer that is not yet active but has a high cha...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Evaluation of Skin Tests in Biotherapy Allergies

NCT ID: NCT06971848

This clinical trial, titled "Evaluation of Skin Tests in Biotherapy Allergies," is studying how to better identify allergic reactions in patients receiving certain biotherapy treatments. Biotherapi...

Not yet recruiting

Phase: NA Type: interventional Locations: Angers, , France

Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma

NCT ID: NCT06947083

This clinical trial is studying a new treatment called Elranatamab, which is given to patients who have high-risk relapsed myeloma after they have received another therapy called cilta-cel. The mai...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tampa, Florida, United States

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

NCT ID: NCT06944119

This clinical trial is studying how well the RSV vaccine works in patients with certain blood cancers, such as multiple myeloma, lymphoma, and leukemia. Researchers want to find out how the immune ...

Recruiting

Type: observational Locations: Tel Aviv, , Israel

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

NCT ID: NCT04268199

**Trial Summary: Exploring Home Administration of Chemotherapy for Myeloma** This clinical trial is looking into whether patients with myeloma can safely give themselves a specific chemotherapy tr...

Recruiting

Phase: PHASE2 Type: interventional Locations: Edmonton, Alberta, Canada, Calgary, Alberta, Canada +1 more

Pilot Imaging Study of Leukemia

NCT ID: NCT03633955

This clinical trial is looking at a new imaging method to help doctors understand how well certain treatments are working for patients with types of blood cancers, such as acute lymphocytic leukemi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Washington, District Of Columbia, United States +1 more

Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL

NCT ID: NCT00881920

The CHARKALL clinical trial is studying a new treatment for patients with certain types of cancer, specifically non-Hodgkin lymphoma, multiple myeloma, or chronic lymphocytic leukemia, that have ei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

NCT ID: NCT05745285

This clinical trial is studying how the services and programs offered by the Leukemia and Lymphoma Society (LLS) affect patients with blood cancers like leukemia, lymphoma, and myeloma. The goal is...

Recruiting

Phase: NA Type: interventional Locations: Chicago, Illinois, United States, Miami, Florida, United States +1 more

HEME Home Transfusion Program

NCT ID: NCT06487247

The HEME Home Transfusion Program is a research study designed to explore a new way of providing blood transfusions to patients with certain blood cancers, like leukemia and lymphoma, in the comfor...

Not yet recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma

NCT ID: NCT04680468

This clinical trial is studying a new treatment called belantamab mafodotin for patients with multiple myeloma, a type of cancer that affects the blood. This treatment will be given to participants...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Philadelphia, Pennsylvania, United States

A Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma

NCT ID: NCT05651932

This clinical trial is studying a new medication designed to treat adults with relapsed or refractory multiple myeloma, a type of blood cancer that has not responded to previous treatments. The dru...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Boston, Massachusetts, United States +27 more

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

NCT ID: NCT06518551

This clinical trial is studying a combination of treatments—Elotuzumab, Iberdomide, and Dexamethasone—given to patients with relapsed and refractory multiple myeloma after they have received a ther...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +1 more

Non-invasive MRD Assessment in Multiple Myeloma

NCT ID: NCT05625971

This clinical trial is looking at new ways to check for minimal residual disease (MRD) in patients with multiple myeloma, a type of blood cancer. The researchers want to see if they can use a simpl...

Recruiting

Type: observational Locations: New York, New York, United States

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

NCT ID: NCT03702309

The Liquid Biopsy Evaluation and Repository Development trial at Princess Margaret Cancer Centre is studying a new way to understand and monitor different types of cancer, including breast, lung, a...

Recruiting

Type: observational Locations: Toronto, Ontario, Canada, Toronto, Ontario, Canada

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

NCT ID: NCT06430736

The PRONTO Trial is researching how a medication called Tocilizumab can help patients with blood cancers like myeloma, lymphoma, and leukemia. Specifically, the trial is looking at whether giving T...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bern, Be, Switzerland

Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients

NCT ID: NCT03832127

This clinical trial, called "Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients," is studying a new imaging method to help diagn...

Recruiting

Phase: PHASE1 Type: interventional Locations: Caen, , France, Nantes, , France +5 more

PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications

NCT ID: NCT06450821

The PROSpECT-PRIOR-2-CHEMO trial is a study designed to see if treating dental health issues before starting chemotherapy can help patients with certain blood cancers, like myeloma, avoid complicat...

Not yet recruiting

Phase: NA Type: interventional Locations: Leeds, West Yorkshire, United Kingdom

Bergamo Lymphoid Cancer Registry

NCT ID: NCT03131531

The Bergamo Lymphoid Cancer Registry is a research study aimed at understanding more about lymphoid cancers, which include Hodgkin lymphoma, non-Hodgkin lymphoma, and myeloma. By collecting informa...

Recruiting

Type: observational Locations: Bergamo, , Italy

European Rare Blood Disorders Platform (ENROL)

NCT ID: NCT06250595

The ENROL trial, also known as the European Rare Blood Disorders Platform, is focused on improving the understanding and treatment of rare blood disorders, which include conditions like anemia, leu...

Recruiting

Type: observational Locations: Barcelona, Catalunya, Spain

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions